Pinnacle Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.32M Sell
93,615
-27,240
-23% -$2.2M 0.08% 224
2026
Q1
$10.5M Buy
120,855
+4,305
+4% +$412K 0.13% 161
2025
Q4
$11.2M Sell
116,550
-3,621
-3% -$352K 0.14% 150
2025
Q3
$11.4M Sell
120,171
-188
-0.2% -$17.3K 0.15% 149
2025
Q2
$10.5M Sell
120,359
-885
-0.7% -$75.1K 0.15% 154
2025
Q1
$10.9M Buy
121,244
+815
+0.7% +$72.9K 0.16% 142
2024
Q4
$9.62M Buy
120,429
+1,542
+1% +$133K 0.13% 168
2024
Q3
$9.79M Sell
118,887
-12,975
-10% -$1.09M 0.17% 152
2024
Q2
$10.4M Buy
131,862
+5,931
+5% +$486K 0.16% 153
2024
Q1
$11M Buy
125,931
+7,044
+6% +$601K 0.17% 150
2023
Q4
$9.79M Buy
118,887
+23,149
+24% +$1.76M 0.16% 155
2023
Q3
$7.5M Buy
95,738
+10,666
+13% +$893K 0.14% 177
2023
Q2
$7.49M Buy
85,072
+32,121
+61% +$2.77M 0.13% 180
2023
Q1
$4.27M Buy
52,951
+8,993
+20% +$733K 0.09% 220
2022
Q4
$3.42M Sell
43,958
-6,603
-13% -$535K 0.07% 241
2022
Q3
$4.08M Sell
50,561
-12,890
-20% -$1.16M 0.09% 218
2022
Q2
$5.7M Sell
63,451
-3,108
-5% -$315K 0.12% 191
2022
Q1
$7.38M Buy
66,559
+10,154
+18% +$1.07M 0.13% 179
2021
Q4
$5.83M Buy
56,405
+6,873
+14% +$796K 0.1% 208
2021
Q3
$6.21M Sell
49,532
-1,069
-2% -$138K 0.11% 198
2021
Q2
$6.28M Buy
50,601
+5,182
+11% +$651K 0.11% 189
2021
Q1
$5.37M Sell
45,419
-178
-0.4% -$20.9K 0.1% 199
2020
Q4
$5.34M Sell
45,597
-250
-0.5% -$27.5K 0.11% 189
2020
Q3
$4.76M Buy
45,847
+2,686
+6% +$270K 0.11% 190
2020
Q2
$3.96M Buy
43,161
+1,752
+4% +$168K 0.1% 202
2020
Q1
$3.73M Sell
41,409
-582
-1% -$61.9K 0.11% 189
2019
Q4
$4.76M Sell
41,991
-382
-0.9% -$41.9K 0.1% 205
2019
Q3
$4.6M Sell
42,373
-1,125
-3% -$117K 0.11% 206
2019
Q2
$4.24M Sell
43,498
-1,125
-3% -$103K 0.1% 218
2019
Q1
$4.06M Sell
44,623
-1,272
-3% -$114K 0.09% 229
2018
Q4
$4.17M Sell
45,895
-5,588
-11% -$522K 0.11% 208
2018
Q3
$5.06M Sell
51,483
-2,659
-5% -$246K 0.11% 208
2018
Q2
$4.63M Sell
54,142
-903
-2% -$75.4K 0.1% 214
2018
Q1
$4.42M Sell
55,045
-11,922
-18% -$983K 0.09% 222
2017
Q4
$5.41M Sell
66,967
-11,317
-14% -$906K 0.1% 200
2017
Q3
$6.09M Buy
78,284
+4,168
+6% +$346K 0.11% 186
2017
Q2
$6.58M Sell
74,116
-1,796
-2% -$151K 0.13% 175
2017
Q1
$6.12M Sell
75,912
-63,703
-46% -$4.98M 0.12% 181
2016
Q4
$9.95M Buy
139,615
+14,705
+12% +$1.16M 0.2% 128
2016
Q3
$10.8M Sell
124,910
-12,941
-9% -$1.13M 0.22% 118
2016
Q2
$12M Sell
137,851
-801
-0.6% -$64.8K 0.26% 110
2016
Q1
$10.4M Sell
138,652
-7,201
-5% -$542K 0.22% 120
2015
Q4
$11.2M Sell
145,853
-3,117
-2% -$235K 0.24% 114
2015
Q3
$9.97M Sell
148,970
-15,361
-9% -$1.13M 0.22% 113
2015
Q2
$12.2M Sell
164,331
-9,462
-5% -$723K 0.23% 108
2015
Q1
$13.6M Buy
173,793
+50,924
+41% +$3.86M 0.25% 95
2014
Q4
$8.87M Buy
122,869
+336
+0.3% +$23.3K 0.17% 136
2014
Q3
$7.59M Buy
122,533
+293
+0.2% +$18.6K 0.15% 149
2014
Q2
$7.79M Sell
122,240
-871
-0.7% -$52.9K 0.15% 143
2014
Q1
$7.58M Sell
123,111
-17,309
-12% -$1.01M 0.15% 142
2013
Q4
$8.06M Sell
140,420
-286
-0.2% -$16.2K 0.16% 135
2013
Q3
$7.49M Sell
140,706
-6,397
-4% -$344K 0.16% 136
2013
Q2
$7.57M Buy
+147,103
New +$7.27M 0.17% 134

Other funds holding MDT

Pinnacle Associates's MDT Position: Q2 2026 in Review

Pinnacle Associates reduced its Medtronic (MDT) stake by 23% in Q2 2026, selling an estimated $2.2M and leaving 93,615 shares worth $7.32M. The position accounts for 0.08% of the portfolio, ranked #224.

Pinnacle Associates first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.6M in Q1 2015. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pinnacle Associates held 93,615 shares of Medtronic worth $7.32M as of Q2 2026.
  • Pinnacle Associates sold 27,240 Medtronic shares in Q2 2026, an estimated $2.2M.
  • Medtronic made up 0.08% of Pinnacle Associates's portfolio in Q2 2026, its #224 holding.
  • Pinnacle Associates first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Pinnacle Associates's Medtronic position peaked at $13.6M in Q1 2015.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.